FCER2 and tuberculosis: It has been reported that unswitched B cells (CD23−) are decreased in ATB but increase post-treatment compared with other lung diseases, suggesting their potential utility as TB treatment response biomarkers (19, 20), but the CD23 expression on B cells during DR-TB has been little explored.